Your browser doesn't support javascript.
loading
Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant.
Higdon, Melissa M; Baidya, Anurima; Walter, Karoline K; Patel, Minal K; Issa, Hanane; Espié, Emmanuelle; Feikin, Daniel R; Knoll, Maria Deloria.
Afiliación
  • Higdon MM; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA. Electronic address: mhigdon@jhu.edu.
  • Baidya A; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.
  • Walter KK; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.
  • Patel MK; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Issa H; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Espié E; Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
  • Feikin DR; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Knoll MD; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.
Lancet Infect Dis ; 22(8): 1114-1116, 2022 08.
Article en En | MEDLINE | ID: mdl-35752196
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos